About Tigermed

Our Company

Media & Resources

Press Releases

Events

Tigermed Insights

Resource Library

Cloud Classroom

Environment, Social and Governance (ESG)

Sustainability & ESG Report

ESG Management

Corporate Responsibility

Corporate Video

We are committed to supporting our clients in their clinical development in the best possible way.

By Phase

Preclinical

Early Phase

Phase II-III Clinical

Post-Marketing

Real World Study

Preclinical Development

Medicinal Chemistry

Medical Writing

Data Management and Statistical Analysis

Clinical Development Strategy

Decentralized Clinical Trials (DCTs)

Site Management (SMO)

Medical Device / IVD

Multi-region Clinical Trial (MRCT)

Vaccine Clinical Trial

Integrated Capabilities

Medical Imaging

Functional Service Provider (FSP)

Recruitment Management

EDC System

Remote Follow-up Center

Therapeutic Expertise

Cell and Gene Therapy

Central Nervous System

Gastroenterology

Ophthalmology

Careers

Talent Development

Enjoy Your Life with Tigermed

Join Tigermed

Global Locations

Discover our offices across Asia, US, Europe, Latin America and Africa.

Career Opportunities

Explore your career opportunities worldwide with Tigermed.

Investors

Corporate Governance

Financial Reports and Presentations

Announcements

Prospectus

Investor Contact

Tigermed 2024 Interim Results Presentation

View Tigermed 2024 Interim Results Presentation

INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024

Contact

Business Enquiry / RFP

Client Service Center

Media & Investors Enquiry

Compliance Concern

Business Enquiry / RFP

Email: marketing@tigermedgrp.com

Client Service Center

Email：clientservice@tigermedgrp.com
Tel：+86 400 070 7751

Media & Investors Enquiry

Email：PR@tigermedgrp.com

Compliance Concern

Email: compliance.officer@tigermedgrp.com

QUICK LINKS

Preclinical

Early Phase

Phase II-III Clinical

Post-Marketing

Real World Study

Tigermed

Celebrating 20 Years of Tigermed

Enabling Life-Changing Therapies with

Excellence and Commitment

Global Employees: 10,000+
Global Customers: 3,200+
Global Offices and Locations: 180+
Innovative Drugs Supported: 117

A Full Suite of CRO Capabilities

Integrated Platform with End-to-End Services

Development Services_2
Manufacturing Services_2
Analytical Services
Analytical Services

Preclinical Development: Your Partner for Preclinical Research and Development with One-Stop Platform and Solutions.

Clinical Development: Providing flexible approach and end-to-end clinical services to support global advance of life-saving therapies.

Integrated Services: Leveraging our top-notch technology and platform to improve clinical study outcomes.

Real World Study: Maximize the value of your product through real world data and innovative approaches.

Preclinical Development

Clinical Development

Integrated Services

Real World Study

Tigermed Insights

Sharing Knowledge for Better Research

At Tigermed, we believe knowledge needs to be shared to further develop clinical programs, increase market access, and to meet unmet patients needs.

Navigating Challenges and Best Practices for Regulatory and Clinical Success in Cell and Gene Therapies

Making Your Mark in the Competitive GLP-1 Market

Embracing Decentralized Tools for a More Cost-Effective Trial

Stay Connected with Tigermed

Sign up to receive our newsletter on hands-on expertise, industry news, changing legislation and tips on practical solutions to industry challenges.

Tigermed promises that any information you provide on this website, including your personal information, will be strictly confidential in accordance with relevant laws and regulations and the provisions of Tigermed Privacy Policy. For more information, see the Privacy Policy.

By submitting this form, you agree to our Privacy Policy, and Tigermed will process the personal data you submit to us during the enquiry process according to Tigermed Privacy Policy.